Company
telehealth platform
Every investor coverage indicates participated in a round Coviu raised.
Investors whose own portfolio pages list Coviu, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Giant Leap | its portfolio page ↗ |
| Main Sequence Ventures | its portfolio page ↗ |
Companies Coviu acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Silvia Pfeiffer | CEO | Women's Agenda |
| Dr Amandeep Hansra | Director | Startup Daily |
| Dr Silvia Pfeiffer | Non-executive Director | Startup Daily |
Stories naming Coviu. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Doctor-led syndicate Medical Angels is turning its backing of 30-plus health startups into a $40 million fund, with $4 million banked, and has recruited former Startmate chief Michal Batko as venture partner.
Profile of doctor-led angel syndicate Australian Medical Angels covering LaunchVic grants, $300,000 toward a new venture fund, a clinician pre-accelerator, and investments including WeGuide and Coviu.
SmartCompany reports digital health platform Updoc raised $20 million from ASX-listed investor Bailador, its first external capital, and notes the telehealth sector's recent funding activity, including InstantScripts' earlier sale to Wesfarmers.
Also Startup Daily·SmartCompany·Startup Daily·SmartCompany·Forbes Australia·Forbes Australia·Forbes Australia
Coviu's cofounder Dr Silvia Pfeiffer has stepped away from the chief executive role at the telehealth business, keeping a board seat; the article also recalls its early venture raises.
A Sydney GP who co-founded a medical investment syndicate has taken a principal role at a deep tech venture fund, joining shortly after another investor's promotion there.
Australia's Main Sequence has pulled in A$250 million for its second deep tech fund, with existing backers returning and a sharpened emphasis on decarbonisation investments.